Perioperative management of the child on long-term opioids

Paediatric Anaesthesia

Volumn 22, Issue 3, 2012, Pages 189-202

  Geary, Tim ^a   Negus, Anna ^a   Anderson, Brian J ^b   Zernikow, Boris ^c  

^a STARSHIP CHILDREN S HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

analgesia; anesthesia; children; opioids; pain

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BACLOFEN; BENZODIAZEPINE DERIVATIVE; BISPHOSPHONIC ACID DERIVATIVE; BUPRENORPHINE; CLONIDINE; CODEINE; CORTICOSTEROID; DEXMEDETOMIDINE; FENTANYL; FENTANYL CITRATE; GABAPENTIN; HYDROMORPHONE; KETAMINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; METHADONE; MORPHINE; NALOXONE; NONSTEROID ANTIINFLAMMATORY AGENT; ONDANSETRON; OPIATE; OXYCODONE; PARACETAMOL; SUFENTANIL; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ALLODYNIA; ANALGESIA; BONE PAIN; BREAKTHROUGH PAIN; CANCER PAIN; CHRONIC PAIN; CONSTIPATION; CONTINUOUS INFUSION; CONTROLLED RELEASE FORMULATION; COPING BEHAVIOR; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CROSS TOLERANCE; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG FORMULATION; DRUG INDICATION; DRUG MEGADOSE; DRUG OVERDOSE; DRUG POTENTIATION; DYSESTHESIA; EPILEPSY; HEPATIC CAPSULAR DISTENSION; HOSPITAL DISCHARGE; HUMAN; LOCAL ANESTHESIA; LONG TERM CARE; LOW DRUG DOSE; MENTAL INSTABILITY; MUSCLE SPASM; NERVE BLOCK; NERVE COMPRESSION; NEURALGIA; NEUROPATHIC PAIN; NURSE CONTROLLED ANALGESIA; OPIATE ADDICTION; OSTEOGENESIS IMPERFECTA; OSTEOPOROSIS; PAIN; PALLIATIVE THERAPY; PANCREATITIS; PARENT; PATIENT CONTROLLED ANALGESIA; PATIENT EDUCATION; PEDIATRIC ANESTHESIA; PEDIATRIC SURGERY; PERIOPERATIVE PERIOD; PLAY THERAPY; POSTANESTHESIA CARE; POSTOPERATIVE ANALGESIA; POSTOPERATIVE CARE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; QT PROLONGATION; RECOVERY ROOM; REGIONAL ANESTHESIA; RESPIRATION DEPRESSION; REVIEW; SEDATION; SEIZURE; SEROTONIN SYNDROME; SIDE EFFECT; TORSADE DES POINTES; TRANSCUTANEOUS NERVE STIMULATION; TRANSDERMAL PATCH; TREATMENT PLANNING; VASCULAR ACCESS; VISCERAL PAIN; WITHDRAWAL SYNDROME;

ANALGESIA, PATIENT-CONTROLLED; ANALGESICS, OPIOID; ANESTHESIA, CONDUCTION; CATHETERS, INDWELLING; CHILD; CHRONIC PAIN; HUMANS; INTENSIVE CARE; INTRAOPERATIVE CARE; LONG-TERM CARE; NERVE BLOCK; PAIN MANAGEMENT; PARENTS; PATIENT EDUCATION AS TOPIC; PERIOPERATIVE CARE; PERIPHERAL NERVES; PREOPERATIVE CARE;

EID: 84856246141     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2011.03737.x     Document Type: Review

References (120)

1. Brill S, Ginosar Y, Davidson EM,. Perioperative management of chronic pain patients with opioid dependency. Curr Opin Anaesthesiol 2006; 19: 325-331. (Pubitemid 43864719)
2. Carroll IR, Angst MS, Clark JD,. Management of perioperative pain in patients chronically consuming opioids. Reg Anesth Pain Med 2004; 29: 576-591. (Pubitemid 40039995)
3. Kopf A, Banzhaf A, Stein C,. Perioperative management of the chronic pain patient. Best Pract Res Clin Anaesthesiol 2005; 19: 59-76. (Pubitemid 39646759)
4. Mehta V, Langford RM,. Acute pain management for opioid dependent patients. Anaesthesia 2006; 61: 269-276. (Pubitemid 43337368)
5. Mitra S, Sinatra RS,. Perioperative management of acute pain in the opioid-dependent patient. Anesthesiology 2004; 101: 212-227. (Pubitemid 38833284)
6. Peng PW, Tumber PS, Gourlay D,. Review article: perioperative pain management of patients on methadone therapy. Can J Anaesth 2005; 52: 513-523. (Pubitemid 40883313)
7. Hadi I, Morley-Forster PK, Dain S, et al. Brief review: perioperative management of the patient with chronic non-cancer pain. Can J Anaesth 2006; 53: 1190-1199.
8. Rozen D, Grass GW,. Perioperative and intraoperative pain and anesthetic care of the chronic pain and cancer pain patient receiving chronic opioid therapy. Pain Pract 2005; 5: 18-32. (Pubitemid 41664182)
9. Swenson JD, Davis JJ, Johnson KB,. Postoperative care of the chronic opioid-consuming patient. Anesthesiol Clin North America 2005; 23: 37-48. (Pubitemid 40349153)
10. de Leon-Casasola OA,. Postoperative pain management in opioid-tolerant patients. Reg Anesth 1996; 21: 114-116. (Pubitemid 126841561)
11. MacIntyre PE, Schug SA, Scott DA, et al. Acute Pain Management: Scientific Evidence, 3rd edn. Working Group of the Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine. Melbourne: ANZCA & FPM, 2010.
12. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009; 10: 113-130.
13. de Leon-Casasola OA, Myers DP, Donaparthi S, et al. A comparison of postoperative epidural analgesia between patients with chronic cancer taking high doses of oral opioids versus opioid-naive patients. Anesth Analg 1993; 76: 302-307. (Pubitemid 23085736)
14. Rapp SE, Ready LB, Nessly ML,. Acute pain management in patients with prior opioid consumption: a case-controlled retrospective review. Pain 1995; 61: 195-201.
15. Colvin LA, Fallon MT,. Opioid-induced hyperalgesia: a clinical challenge. Br J Anaesth 2010; 104: 125-127.
16. McDowall RH,. Anesthesia considerations for pediatric cancer. Semin Surg Oncol 1993; 9: 478-488. (Pubitemid 23358470)
17. Karl HW, Rosenberger JL, Larach MG, et al. Transmucosal administration of midazolam for premedication of pediatric patients. Comparison of the nasal and sublingual routes. Anesthesiology 1993; 78: 885-891. (Pubitemid 23141364)
18. Wheeler M, Birmingham PK, Dsida RM, et al. Uptake pharmacokinetics of the Fentanyl Oralet in children scheduled for central venous access removal: implications for the timing of initiating painful procedures. Paediatr Anaesth 2002; 12: 594-599. (Pubitemid 35266464)
19. Johnson RE, Fudala PJ, Payne R,. Buprenorphine: considerations for pain management. J Pain Symptom Manage 2005; 29: 297-326. (Pubitemid 40386746)
20. Michel E, Anderson BJ, Zernikow B,. Buprenorphine TTS for children-a review of the drug's clinical pharmacology. Pediatr Anesth 2011; 21: 280-290.
21. Nunn T, Williams J,. Formulation of medicines for children. Br J Clin Pharmacol 2005; 59: 674-676. (Pubitemid 40835500)
22. Herd DW, Salehi B,. Palatability of two forms of paracetamol (acetaminophen) suspension: a randomised trial. Paediatr Perinat Drug Ther 2006; 7: 189-193. (Pubitemid 46438577)
23. Merry AF, Anderson BJ,. Medication errors-new approaches to prevention. Pediatr Anesth 2011; 21: 743-753.
24. Allegaert K, Anderson BJ, Vrancken M, et al. Impact of a paediatric vial on the magnitude of systematic medication errors in preterm neonates: amikacin as an example. Paediatr Perinat Drug Ther 2006; 7: 59-63. (Pubitemid 44299033)
25. McMillan C, Young S, Anderson BJ,. Practicality of dose prescriptions in PICU. Paediatr Perinat Drug Ther 2007; 8: 96-100.
26. Zernikow B, Schiessl C, Wamsler C,. [Long-term pediatric opioid based pain control. Case reports]. Schmerz 2005; 19: 418-425. (Pubitemid 41380767)
27. Finkel JC, Finley A, Greco C, et al. Transdermal fentanyl in the management of children with chronic severe pain: results from an international study. Cancer 2005; 104: 2847-2857. (Pubitemid 41798297)
28. Wokovich AM, Prodduturi S, Doub WH, et al. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute. Eur J Pharm Biopharm 2006; 64: 1-8. (Pubitemid 44150598)
29. American Academy of Pediatrics. Committee on Drugs. Alternative routes of drug administration-advantages and disadvantages (subject review). Pediatrics 1997; 100: 143-152.
30. Tanner T, Marks R,. Delivering drugs by the transdermal route: review and comment. Skin Res Technol 2008; 14: 249-260.
31. Zernikow B, Lindena G,. Long-acting morphine for pain control in paediatric oncology. Med Pediatr Oncol 2001; 36: 451-458. (Pubitemid 32240459)
32. Fredheim OM, Log T, Olsen W, et al. Prescriptions of opioids to children and adolescents; a study from a national prescription database in Norway. Pediatr Anesth 2010; 20: 537-544.
33. Zernikow B, Michel E, Craig F, et al. Pediatric palliative care: use of opioids for the management of pain. Paediatr Drugs 2009; 11: 129-151.
34. The Royal Australasian College of Physicians. Prescription Opioid Policy: improving management of chronic non-malignant pain and prevention of problems associated with prescription opioid use. 2009. Available at: http://www.racp.edu.au. Accessed 15 September 2011.
35. Arnold JH, Truog RD, Orav EJ, et al. Tolerance and dependence in neonates sedated with fentanyl during extracorporeal membrane oxygenation. Anesthesiology 1990; 73: 1136-1140.
36. Dewey WL,. Various factors which affect the rate of development of tolerance and physical dependence to abused drugs. NIDA Res Monogr 1984; 54: 39-49. (Pubitemid 15228910)
37. Birchley G,. Opioid and benzodiazepine withdrawal syndromes in the paediatric intensive care unit: a review of recent literature. Nurs Crit Care 2009; 14: 26-37.
38. Tobias JD,. Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit. Crit Care Med 2000; 28: 2122-2132. (Pubitemid 30428787)
39. Ista E, van Dijk M, Gamel C, et al. Withdrawal symptoms in children after long-term administration of sedatives and/or analgesics: a literature review. "Assessment remains troublesome". Intensive Care Med 2007; 33: 1396-1406. (Pubitemid 47101702)
40. Marsch LA, Bickel WK, Badger GJ, et al. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial. Arch Gen Psychiatry 2005; 62: 1157-1164. (Pubitemid 41396941)
41. Hechler T, Kosfelder J, Vocks S, et al. Changes in pain-related coping strategies and their importance for treatment outcome following multimodal inpatient treatment: does sex matter? J Pain 2010; 11: 472-483.
42. Sherry DD,. An overview of amplified musculoskeletal pain syndromes. J Rheumatol Suppl 2000; 58: 44-48. (Pubitemid 30340294)
43. Latham GJ, Greenberg RS,. Anesthetic considerations for the pediatric oncology patient-part 1: a review of antitumor therapy. Pediatr Anesth 2010; 20: 295-304.
44. Latham GJ, Greenberg RS,. Anesthetic considerations for the pediatric oncology patient-part 3: pain, cognitive dysfunction, and preoperative evaluation. Pediatr Anesth 2010; 20: 479-489.
45. Latham GJ, Greenberg RS,. Anesthetic considerations for the pediatric oncology patient-part 2: systems-based approach to anesthesia. Pediatr Anesth 2010; 20: 396-420.
46. Hatava P, Olsson GL, Lagerkranser M,. Preoperative psychological preparation for children undergoing ENT operations: a comparison of two methods. Paediatr Anaesth 2000; 10: 477-486.
47. Lonnqvist PA, Morton NS, Ross AK,. Consent issues and pediatric regional anesthesia. Pediatr Anesth 2009; 19: 958-960.
48. Howard R, Carter B, Curry J, et al. Analgesia review. Pediatr Anesth 2008; 18 (Suppl. 1): 64-78.
49. LaMontagne LL, Hepworth JT, Cohen F, et al. Cognitive-behavioral intervention effects on adolescents' anxiety and pain following spinal fusion surgery. Nurs Res 2003; 52: 183-190.
50. DuHamel KN, Redd WH, Vickberg SM,. Behavioral interventions in the diagnosis, treatment and rehabilitation of children with cancer. Acta Oncol 1999; 38: 719-734. (Pubitemid 29441434)
51. Eccleston C, Malleson PN, Clinch J, et al. Chronic pain in adolescents: evaluation of a programme of interdisciplinary cognitive behaviour therapy. Arch Dis Child 2003; 88: 881-885. (Pubitemid 37194043)
52. Palermo TM, Eccleston C,. Parents of children and adolescents with chronic pain. Pain 2009; 146: 15-17.
53. Albanese CT, Wiener ES,. Venous access in pediatric oncology patients. Semin Surg Oncol 1993; 9: 467-477. (Pubitemid 23358469)
54. Murphy DB, Sutton A, Prescott LF, et al. A comparison of the effects of tramadol and morphine on gastric emptying in man. Anaesthesia 1997; 52: 1224-1229. (Pubitemid 27511267)
55. Rosti G, Gatti A, Costantini A, et al. Opioid-related bowel dysfunction: prevalence and identification of predictive factors in a large sample of Italian patients on chronic treatment. Eur Rev Med Pharmacol Sci 2010; 14: 1045-1050.
56. Tuteja AK, Biskupiak J, Stoddard GJ, et al. Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain. Neurogastroenterol Motil 2010; 22: 424-430, e496.
57. Frolich MA, Giannotti A, Modell JH,. Opioid overdose in a patient using a fentanyl patch during treatment with a warming blanket. Anesth Analg 2001; 93: 647-648. (Pubitemid 32783289)
58. Heiskanen T, Matzke S, Haakana S, et al. Transdermal fentanyl in cachectic cancer patients. Pain 2009; 144: 218-222.
59. Sansone RA, Sansone LA,. Tramadol: seizures, serotonin syndrome, and coadministered antidepressants. Psychiatry (Edgmont) 2009; 6: 17-21.
60. Nathan AT, Berkowitz DH, Montenegro LM, et al. Implications of anesthesia in children with long QT syndrome. Anesth Analg 2011; 112: 1163-1168.
61. Glaisyer HR, Sury MR,. Recovery after anesthesia for short pediatric oncology procedures: propofol and remifentanil compared with propofol, nitrous oxide, and sevoflurane. Anesth Analg 2005; 100: 959-963. (Pubitemid 40404195)
62. Davis JJ, Johnson KB, Egan TD, et al. Preoperative fentanyl infusion with pharmacokinetic simulation for anesthetic and perioperative management of an opioid-tolerant patient. Anesth Analg 2003; 97: 1661-1662. (Pubitemid 37475118)
63. Davis JJ, Swenson JD, Hall RH, et al. Preoperative "fentanyl challenge" as a tool to estimate postoperative opioid dosing in chronic opioid-consuming patients. Anesth Analg 2005; 101: 389-395. (Pubitemid 41045219)
64. Devulder J, Jacobs A, Richarz U, et al. Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant pain. Br J Anaesth 2009; 103: 576-585.
65. Mystakidou K, Panagiotou I, Gouliamos A,. Fentanyl nasal spray for the treatment of cancer pain. Expert Opin Pharmacother 2011; 12: 1653-1659.
66. Borland M, Jacobs I, King B, et al. A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department. Ann Emerg Med 2007; 49: 335-340.
67. Mystakidou K, Tsilika E, Tsiatas M, et al. Oral transmucosal fentanyl citrate in cancer pain management: a practical application of nanotechnology. Int J Nanomedicine 2007; 2: 49-54. (Pubitemid 46901781)
68. Nalamachu SR, Narayana A, Janka L,. Long-term dosing, safety, and tolerability of fentanyl buccal tablet in the management of noncancer-related breakthrough pain in opioid-tolerant patients. Curr Med Res Opin 2011; 27: 751-760.
69. Fine PG, Narayana A, Passik SD,. Treatment of breakthrough pain with fentanyl buccal tablet in opioid-tolerant patients with chronic pain: appropriate patient selection and management. Pain Med 2010; 11: 1024-1036.
70. Davis MP,. Fentanyl for breakthrough pain: a systematic review. Expert Rev Neurother 2011; 11: 1197-1216.
71. Davies D, DeVlaming D, Haines C,. Methadone analgesia for children with advanced cancer. Pediatr Blood Cancer 2008; 51: 393-397.
72. Sabatowski R, Kasper SM, Radbruch L,. Patient-controlled analgesia with intravenous l-methadone in a child with cancer pain refractory to high-dose morphine. J Pain Symptom Manage 2002; 23: 3-5. (Pubitemid 34093872)
73. Roberts DM, Meyer-Witting M,. High-dose buprenorphine: perioperative precautions and management strategies. Anaesth Intensive Care 2005; 33: 17-25. (Pubitemid 40287592)
74. Czarnecki ML, Jandrisevits MD, Theiler SC, et al. Controlled-release oxycodone for the management of pediatric postoperative pain. J Pain Symptom Manage 2004; 27: 379-386. (Pubitemid 38410906)
75. Meissner W, Leyendecker P, Mueller-Lissner S, et al. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation. Eur J Pain 2009; 13: 56-64.
76. May JA, White HC, Leonard-White A, et al. The patient recovering from alcohol or drug addiction: special issues for the anesthesiologist. Anesth Analg 2001; 92: 1601-1608. (Pubitemid 32493191)
77. Wang JK, Nauss LA, Thomas JE,. Pain relief by intrathecally applied morphine in man. Anesthesiology 1979; 50: 149-151. (Pubitemid 9130744)
78. de Leon-Casasola OA, Lema MJ,. Epidural bupivacaine/sufentanil therapy for postoperative pain control in patients tolerant to opioid and unresponsive to epidural bupivacaine/morphine. Anesthesiology 1994; 80: 303-309. (Pubitemid 24064033)
79. Dabbagh A, Dahi-Taleghani M, Elyasi H, et al. Duration of spinal anesthesia with bupivacaine in chronic opium abusers undergoing lower extremity orthopedic surgery. Arch Iran Med 2007; 10: 316-320. (Pubitemid 47177091)
80. Souzdalnitski D, Halaszynski TM, Faclier G,. Regional anesthesia and co-existing chronic pain. Curr Opin Anaesthesiol 2010; 23: 662-670.
81. Horlocker TT, Burton AW, Connis RT, et al. Practice guidelines for the prevention, detection, and management of respiratory depression associated with neuraxial opioid administration. Anesthesiology 2009; 110: 218-230.
82. de Leon-Casasola OA, Lema MJ,. Epidural sufentanil for acute pain control in a patient with extreme opioid dependency. Anesthesiology 1992; 76: 853-856.
83. Skinner AV, Chalkiadis GA,. Clinically unrecognized intravascular placement of epidural catheter in a child-an argument for the use of radio-opaque contrast? Pediatr Anesth 2007; 17: 387-392. (Pubitemid 46365128)
84. Ivani G, Mossetti V,. Continuous central and perineural infusions for postoperative pain control in children. Curr Opin Anaesthesiol 2010; 23: 637-642.
85. Dadure C, Bringuier S, Nicolas F, et al. Continuous epidural block versus continuous popliteal nerve block for postoperative pain relief after major podiatric surgery in children: a prospective, comparative randomized study. Anesth Analg 2006; 102: 744-749.
86. Ecoffey C,. Pediatric regional anesthesia-update. Curr Opin Anaesthesiol 2007; 20: 232-235. (Pubitemid 46701338)
87. Lauder GR, White MC,. Neuropathic pain following multilevel surgery in children with cerebral palsy: a case series and review. Pediatr Anesth 2005; 15: 412-420. (Pubitemid 40559487)
88. Wong GT, Yuen VM, Chow BF, et al. Persistent pain in patients following scoliosis surgery. Eur Spine J 2007; 16: 1551-1556. (Pubitemid 47594205)
89. Anghelescu DL, Oakes LL, Hankins GM,. Treatment of pain in children after limb-sparing surgery: an institution's 26-year experience. Pain Manag Nurs 2011; 12: 82-94.
90. Macintyre PE, Schug SA,. Acute Pain Management: A Practical Guide. London: Elsevier, 2007.
91. Basu S, Bruce RD, Barry DT, et al. Pharmacological pain control for human immunodeficiency virus-infected adults with a history of drug dependence. J Subst Abuse Treat 2007; 32: 399-409. (Pubitemid 46661125)
92. Manchikanti L, Fellows B, Ailinani H, et al. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician 2010; 13: 401-435.
93. Drake R, Longworth J, Collins JJ,. Opioid rotation in children with cancer. J Palliat Med 2004; 7: 419-422. (Pubitemid 38980577)
94. Vissers KC, Besse K, Hans G, et al. Opioid rotation in the management of chronic pain: where is the evidence? Pain Pract 2010; 10: 85-93.
95. Mannino R, Coyne P, Swainey C, et al. Methadone for cancer-related neuropathic pain: a review of the literature. J Opioid Manag 2006; 2: 269-276.
96. Gong QL, Hedner J, Bjorkman R, et al. Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat. Pain 1992; 48: 249-255.
97. Smith MT, Watt JA, Cramond T,. Morphine-3-glucuronide-a potent antagonist of morphine analgesia. Life Sci 1990; 47: 579-585. (Pubitemid 20282122)
98. Morton NS, O'Brien K,. Analgesic efficacy of paracetamol and diclofenac in children receiving PCA morphine. Br J Anaesth 1999; 82: 715-717. (Pubitemid 29199745)
99. Hannam J, Anderson BJ,. Explaining the acetaminophen-ibuprofen analgesic interaction using a response surface model. Pediatr Anesth 2011; 21: 1234-1240.
100. Fisher K, Hagen NA,. Analgesic effect of oral ketamine in chronic neuropathic pain of spinal origin: a case report. J Pain Symptom Manage 1999; 18: 61-66. (Pubitemid 29344638)
101. Bell RF, Dahl JB, Moore RA, et al. Perioperative ketamine for acute postoperative pain. Cochrane Database Syst Rev 2006: CD004603.
102. Duncan MA, Spiller JA,. Analgesia with ketamine in a patient with perioperative opioid tolerance. J Pain Symptom Manage 2002; 24: 8-11.
103. Allegaert K, Rochette A, Veyckemans F,. Developmental pharmacology of tramadol during infancy: ontogeny, pharmacogenetics and elimination clearance. Pediatr Anesth 2011; 21: 266-273.
104. Agthe AG, Kim GR, Mathias KB, et al. Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial. Pediatrics 2009; 123: e849-e856.
105. Multz AS,. Prolonged dexmedetomidine infusion as an adjunct in treating sedation-induced withdrawal. Anesth Analg 2003; 96: 1054-1055, table of contents. (Pubitemid 36359042)
106. Rose MA, Kam PC,. Gabapentin: pharmacology and its use in pain management. Anaesthesia 2002; 57: 451-462. (Pubitemid 34477042)
107. Vondracek P, Oslejskova H, Kepak T, et al. Efficacy of pregabalin in neuropathic pain in paediatric oncological patients. Eur J Paediatr Neurol 2009; 13: 332-336.
108. Harmark L, van Puijenbroek E, Straus S, et al. Intensive monitoring of pregabalin: results from an observational, Web-based, prospective cohort study in the Netherlands using patients as a source of information. Drug Saf 2011; 34: 221-231.
109. Heiligenstein E, Steif BL,. Tricyclics for pain. J Am Acad Child Adolesc Psychiatry 1989; 28: 804-805.
110. Angst MS, Clark JD,. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 2006; 104: 570-587.
111. Mao J, Price DD, Mayer DJ,. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 1995; 62: 259-274.
112. Chang G, Chen L, Mao J,. Opioid tolerance and hyperalgesia. Med Clin North Am 2007; 91: 199-211.
113. Hechler T, Martin A, Blankenburg M, et al. Specialized multimodal outpatient treatment for children with chronic pain: treatment pathways and long-term outcome. Eur J Pain 2011; 15: 976-984.
114. Gordon DB, Stevenson KK, Griffie J, et al. Opioid equianalgesic calculations. J Palliat Med 1999; 2: 209-218. (Pubitemid 29325276)
115. Berdine HJ, Nesbit SA,. Equianalgesic dosing of opioids. J Pain Palliat Care Pharmacother 2006; 20: 79-84. (Pubitemid 46018106)
116. Shaheen PE, Walsh D, Lasheen W, et al. Opioid equianalgesic tables: are they all equally dangerous? J Pain Symptom Manage 2009; 38: 409-417.
117. Knotkova H, Fine PG, Portenoy RK,. Opioid rotation: the science and the limitations of the equianalgesic dose table. J Pain Symptom Manage 2009; 38: 426-439.
118. Pereira J, Lawlor P, Vigano A, et al. Equianalgesic dose ratios for opioids. A critical review and proposals for long-term dosing. J Pain Symptom Manage 2001; 22: 672-687. (Pubitemid 32725810)
119. Lawlor PG, Turner KS, Hanson J, et al. Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study. Cancer 1998; 82: 1167-1173. (Pubitemid 28136533)
120. Cherny N, Ripamonti C, Pereira J, et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 2001; 19: 2542-2554. (Pubitemid 32391226)